- Email: [email protected]
1202. A Potent HSVtk Mutant for Cancer Gene Therapy
"? - D*!/ '@
!"= C C"; #?"; '$.'@@,!2%!*!
@8::8 ' '$.'@@,!2%!*! - M 89/ D*! 31 @8::8-$&9L89#/ ? -$&9L9,%/ !"=#?" ; C C"; ? @8::8%?
D*! '$.'@@,!2%!*!"@>("> ?!
'$.#.%C(.
. ? % D*! 3 -L 899 =/ E
'$.'@@,!2%!*! '$.'@@,!2% > ?!
? -,9 % % /
&
'$.'@@,!2% !*!
3 D*!
)
1200. Enhancement of T ransgene Expression Using Transgene an Epstein-Barr V irus Replicon V ector System: Virus Vector Applications to Gene Therapy for Cancer Seiji Yamamoto,1 Takanobu Otomo,1 Yoshinaga Saeki,1 Ryuichi Morishita,1 Yasufumi Kaneda.1 1 Division of Gene Therapy Science, Osaka University School of Medicine, Suita, Osaka, Japan. )E 7 ' E
3 ? " 3 > "2 ->2./
3
>2.
# # 7 ' >2. >2 >2. "8 ->2*'"8/ $*' !
3 ->2D / 3 ->2 / 3
-28B?/ C.<" "
3 >2.
D >2. ( $*'
3 >2*'"8 3
= ; >2D ?
:"
" &;2D%B ( 899 μ C.<" >2
>2*'
; 86 -89 %/ E
= ,9 ' G
@ 7 D 3
>2 D
>2*'"8 3
= ;
>2D (
D >2D
; C (
>2D
D " >2 3
! >2.
C >2 E
86
>2 A 2(( A 7 >2.
" 3
S390
D" 3 >2.
3 $*'
3 ' >2. G
>2.
1201. Cell Growth-Related Midkine Promoter Is Potentially Useful T o Achieve T umor-Specific Expression To Tumor-Specific in Human Breast Cancer and Hepatocellular Carcinoma Ling Yu,1 Minoru Tomizawa,1,2 Kenji Kadomatsu,3 Takashi Muramatsu,3 Shuichiro Matsubara,4 Shigeru Sakiyama,1 Masatoshi Tagawa.1 1 Division of Pathology, Chiba Cancer Center Research Institute, Chiba, Japan; 2Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; 3 Department of Biochemistry, Nagoya University, School of Medicine, Nagoya, Japan; 4Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. # -#A/ 1 3
3
0
G
#A
3
1 &V"
G
0 9B" &V"
,=" 89" 9=" E
C 9B"
" &= 9B" "
&="
0
#A "
3 1 3 4
#A 3
"
8B 8:
3 " 2",
& 3 #A
86 8& = 3
" -'?!/ * "
#A '?! 3 D
#A " 2", '?! #A" '?!"
-#? ; 2 &65/ -C C ; !D%!@?8&/
#A "
3 #A 3
" 2", '?!
1202. A Potent HSVtk Mutant for Cancer Gene Therapy Xiaomei Wang,1 Baomei Gao,1 Yifei Wang,1 Hongyu Zhang,1 Jianren Gu,1 Jingde Zhu.1 1 National Laboratory for Oncogene and Related Genes, Shanghai Cancer Institute, Shanghai, China. C(. % .
C 1
. 3 C(. "
C(. )
G . 8%&
. " 1 2 Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
!"
" C(. . 3
C(. 0
!" 1203. Reconstitution of Cytotoxic Activity in XLP T Cells by SAP Gene T ransfer Transfer Reza Sharifi,1 Adrian J. Thrasher,1 Christine Kinnon,1 Hubert B. Gaspar.1 1 Molecular Immunology Unit, Institute of Child Health, London, United Kingdom. F"
-FD!/
3 > "2 ->2./ '
FD!
FD!
('! -(D'#
/ ('! 2 FD!
3 *A >2. @
'D. - /
(??. -
/ ('!
-/
! -!2# / >2. 3 - D / FD!
3 ('!
?! 3
'
!2# , FD! >2." D FD! >D(!)
3 !#' C ('!
*?" 3
D$C 3 >2." D FD! 3
>2."DD >2." D ('!
FD! >2." D
3
FD! 3
('!
1204. Gene-Modified Autologous Bone Marrow Stroma Embedded in Matrigel ™ Leads to a Matrigel™ Neovascularized Implant for Prolonged In Vivo Systemic Delivery of Functional Erythropoietin Nicoletta Eliopoulos,1 Abdulaziz Al-Khaldi,2 Jacques Galipeau.1,3 1 Department of Experimental Medicine, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada; 2Division of Cardiothoracic Surgery, McGill University Health Center, Montreal, Quebec, Canada; 3Division of Hematology/Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. 2 -#( / #(
G "
#(
#(
#(
E
#(
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
# 3
G
->/ 0
> $*'
- ?!/
!J>:B G
#( &;2%B L6 3 89&
*C = =
#(
8; 4 > 89B ,6
G "
->D('/
6 3 89B #( % 3
# ™ &;2%B
# "
>" #( C
&& ±9;H-# ±(>#/:,±8,HL,
"
:9"59H L,& ;
# "
#(
>"
C L&&H 3 "
#(
DN
#
&;2%B ?
F"
β" 3 #( >" #(
#
"
$=8
# #(
3 # "
"
#(
0 G
1205. Genetically Engineered Autologous Bone Marrow Stromal Cells Embedded in a HumanCompatible, T ype I Bovine Collagen Matrix for Systemic Type Delivery of Erythropoietin Nicoletta Eliopoulos,1 Jacques Galipeau.1,2 1 Department of Experimental Medicine, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada; 2Division of Hematology/Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. 2 -#( /
3
1 3
#(
. #(
0 #(
3
->/
"
#(
" 3 0
>$*'
- ?!/
!J>:B
5;H ?!J
L6 3 89& @
G
#( &;2%B 1
G "
->D('/
S391
!"= C C"; #?"; '$.'@@,!2%!*!
@8::8 ' '$.'@@,!2%!*! - M 89/ D*! 31 @8::8-$&9L89#/ ? -$&9L9,%/ !"=#?" ; C C"; ? @8::8%?
D*! '$.'@@,!2%!*!"@>("> ?!
'$.#.%C(.
. ? % D*! 3 -L 899 =/ E
'$.'@@,!2%!*! '$.'@@,!2% > ?!
? -,9 % % /
&
'$.'@@,!2% !*!
3 D*!
)
1200. Enhancement of T ransgene Expression Using Transgene an Epstein-Barr V irus Replicon V ector System: Virus Vector Applications to Gene Therapy for Cancer Seiji Yamamoto,1 Takanobu Otomo,1 Yoshinaga Saeki,1 Ryuichi Morishita,1 Yasufumi Kaneda.1 1 Division of Gene Therapy Science, Osaka University School of Medicine, Suita, Osaka, Japan. )E 7 ' E
3 ? " 3 > "2 ->2./
3
>2.
# # 7 ' >2. >2 >2. "8 ->2*'"8/ $*' !
3 ->2D / 3 ->2 / 3
-28B?/ C.<" "
3 >2.
D >2. ( $*'
3 >2*'"8 3
= ; >2D ?
:"
" &;2D%B ( 899 μ C.<" >2
>2*'
; 86 -89 %/ E
= ,9 ' G
@ 7 D 3
>2 D
>2*'"8 3
= ;
>2D (
D >2D
; C (
>2D
D " >2 3
! >2.
C >2 E
86
>2 A 2(( A 7 >2.
" 3
S390
D" 3 >2.
3 $*'
3 ' >2. G
>2.
1201. Cell Growth-Related Midkine Promoter Is Potentially Useful T o Achieve T umor-Specific Expression To Tumor-Specific in Human Breast Cancer and Hepatocellular Carcinoma Ling Yu,1 Minoru Tomizawa,1,2 Kenji Kadomatsu,3 Takashi Muramatsu,3 Shuichiro Matsubara,4 Shigeru Sakiyama,1 Masatoshi Tagawa.1 1 Division of Pathology, Chiba Cancer Center Research Institute, Chiba, Japan; 2Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; 3 Department of Biochemistry, Nagoya University, School of Medicine, Nagoya, Japan; 4Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. # -#A/ 1 3
3
0
G
#A
3
1 &V"
G
0 9B" &V"
,=" 89" 9=" E
C 9B"
" &= 9B" "
&="
0
#A "
3 1 3 4
#A 3
"
8B 8:
3 " 2",
& 3 #A
86 8& = 3
" -'?!/ * "
#A '?! 3 D
#A " 2", '?! #A" '?!"
-#? ; 2 &65/ -C C ; !D%!@?8&/
#A "
3 #A 3
" 2", '?!
1202. A Potent HSVtk Mutant for Cancer Gene Therapy Xiaomei Wang,1 Baomei Gao,1 Yifei Wang,1 Hongyu Zhang,1 Jianren Gu,1 Jingde Zhu.1 1 National Laboratory for Oncogene and Related Genes, Shanghai Cancer Institute, Shanghai, China. C(. % .
C 1
. 3 C(. "
C(. )
G . 8%&
. " 1 2 Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
!"
" C(. . 3
C(. 0
!" 1203. Reconstitution of Cytotoxic Activity in XLP T Cells by SAP Gene T ransfer Transfer Reza Sharifi,1 Adrian J. Thrasher,1 Christine Kinnon,1 Hubert B. Gaspar.1 1 Molecular Immunology Unit, Institute of Child Health, London, United Kingdom. F"
-FD!/
3 > "2 ->2./ '
FD!
FD!
('! -(D'#
/ ('! 2 FD!
3 *A >2. @
'D. - /
(??. -
/ ('!
-/
! -!2# / >2. 3 - D / FD!
3 ('!
?! 3
'
!2# , FD! >2." D FD! >D(!)
3 !#' C ('!
*?" 3
D$C 3 >2." D FD! 3
>2."DD >2." D ('!
FD! >2." D
3
FD! 3
('!
1204. Gene-Modified Autologous Bone Marrow Stroma Embedded in Matrigel ™ Leads to a Matrigel™ Neovascularized Implant for Prolonged In Vivo Systemic Delivery of Functional Erythropoietin Nicoletta Eliopoulos,1 Abdulaziz Al-Khaldi,2 Jacques Galipeau.1,3 1 Department of Experimental Medicine, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada; 2Division of Cardiothoracic Surgery, McGill University Health Center, Montreal, Quebec, Canada; 3Division of Hematology/Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. 2 -#( / #(
G "
#(
#(
#(
E
#(
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
# 3
G
->/ 0
> $*'
- ?!/
!J>:B G
#( &;2%B L6 3 89&
*C = =
#(
8; 4 > 89B ,6
G "
->D('/
6 3 89B #( % 3
# ™ &;2%B
# "
>" #( C
&& ±9;H-# ±(>#/:,±8,HL,
"
:9"59H L,& ;
# "
#(
>"
C L&&H 3 "
#(
DN
#
&;2%B ?
F"
β" 3 #( >" #(
#
"
$=8
# #(
3 # "
"
#(
0 G
1205. Genetically Engineered Autologous Bone Marrow Stromal Cells Embedded in a HumanCompatible, T ype I Bovine Collagen Matrix for Systemic Type Delivery of Erythropoietin Nicoletta Eliopoulos,1 Jacques Galipeau.1,2 1 Department of Experimental Medicine, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada; 2Division of Hematology/Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. 2 -#( /
3
1 3
#(
. #(
0 #(
3
->/
"
#(
" 3 0
>$*'
- ?!/
!J>:B
5;H ?!J
L6 3 89& @
G
#( &;2%B 1
G "
->D('/
S391